Korro Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Korro Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q2 2024.
- Korro Bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.1M, a 31.1% decline year-over-year.
- Korro Bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$91.6M, a 73% decline year-over-year.
- Korro Bio, Inc. annual Operating Income (Loss) for 2023 was -$84.5M, a 43.3% decline from 2022.
- Korro Bio, Inc. annual Operating Income (Loss) for 2022 was -$59M, a 29.8% increase from 2021.
- Korro Bio, Inc. annual Operating Income (Loss) for 2021 was -$84M, a 205% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)